Skip to content
Biodatica
Start free

Astellas Pharma Global Development, Inc.

Sacramento, California

OncologyPhase IListed · ALPMY

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Phase I trial registered: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

5d agoTrial registeredJul 15, 2026Source filing (opens the source filing in a new tab)

Momentum

77no change

Momentum 77 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase I

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE1 registered

    Feb 28, 2023

    Advanced Solid Tumors · TERMINATED · sponsor: Astellas Pharma Global Development, Inc. · A Study of ASP2074 in Adults With Solid Tumors

    ClinicalTrials.gov · NCT05646797 (opens the source filing in a new tab)

  2. Trial

    PHASE1 registered

    Jun 7, 2022

    Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma · RECRUITING · sponsor: Astellas Pharma Global Development, Inc. · A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer

    ClinicalTrials.gov · NCT05365581 (opens the source filing in a new tab)

  3. Trial

    PHASE1 registered

    Jun 14, 2021

    Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction · TERMINATED · sponsor: Astellas Pharma Global Development, Inc. · A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction

    ClinicalTrials.gov · NCT04855201 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources